Baidu
map

JACC:医保政策对心衰患者再住院率的影响

2019-03-19 不详 MedSci原创

医疗保险医院减少再入院计划导致主要诊断为心力衰竭(HF)的住院后再入院人数减少,且心衰患者很少因为其他原因再住院。本研究旨在比较主要心衰住院和其他心衰住院后经医疗保险风险调整的30天再入院的趋势。本研究纳入了2008-2015年12973853名主要或次要因为心衰住院的医保患者,住院患者分为以下几类:主要因心衰住院的,主要急性心肌梗死或肺炎继发性心力衰竭住院的,和其他原因继发心衰住院的。在2010

医疗保险医院减少再入院计划导致主要诊断为心力衰竭(HF)的住院后再入院人数减少,且心衰患者很少因为其他原因再住院。本研究旨在比较主要心衰住院和其他心衰住院后经医疗保险风险调整的30天再入院的趋势。

本研究纳入了2008-2015年12973853名主要或次要因为心衰住院的医保患者,住院患者分为以下几类:主要因心衰住院的,主要急性心肌梗死或肺炎继发性心力衰竭住院的,和其他原因继发心衰住院的。在2010年3月通过《可负担医疗法案》之前,三组患者的再住院率比较稳定,每月的再住院率分别为26.1%, 24.9%和24.4%,在法案通过后,三组患者的每年再住院率分别下降了1.09%、1.24%和1.05%,直到2012年10月实施医院再入院减少计划,三组患者的再住院率又稳定下来。

研究结果显示,心衰患者常因其他原因住院,且这些原因的再住院率较高,医保政策的改变会影响主要心衰或继发心衰的再住院率。

原始出处:

本文系梅斯医学(MedSci)原创编译整理,转载需授权

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1663236, encodeId=018d166323690, content=<a href='/topic/show?id=91a330610e0' target=_blank style='color:#2F92EE;'>#再住院率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30610, encryptionId=91a330610e0, topicName=再住院率)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=515025593328, createdName=12498974m59暂无昵称, createdTime=Mon Oct 21 09:20:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1854336, encodeId=9ac1185433615, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Fri Apr 19 01:20:00 CST 2019, time=2019-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933237, encodeId=b57b193323e94, content=<a href='/topic/show?id=f2563386651' target=_blank style='color:#2F92EE;'>#医保政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33866, encryptionId=f2563386651, topicName=医保政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a8d381, createdName=mnda, createdTime=Sat May 11 03:20:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260431, encodeId=23221260431f8, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Thu Mar 21 01:20:00 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326154, encodeId=a85f1326154ff, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Thu Mar 21 01:20:00 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373438, encodeId=10ab13e343880, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Thu Mar 21 01:20:00 CST 2019, time=2019-03-21, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1663236, encodeId=018d166323690, content=<a href='/topic/show?id=91a330610e0' target=_blank style='color:#2F92EE;'>#再住院率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30610, encryptionId=91a330610e0, topicName=再住院率)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=515025593328, createdName=12498974m59暂无昵称, createdTime=Mon Oct 21 09:20:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1854336, encodeId=9ac1185433615, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Fri Apr 19 01:20:00 CST 2019, time=2019-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933237, encodeId=b57b193323e94, content=<a href='/topic/show?id=f2563386651' target=_blank style='color:#2F92EE;'>#医保政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33866, encryptionId=f2563386651, topicName=医保政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a8d381, createdName=mnda, createdTime=Sat May 11 03:20:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260431, encodeId=23221260431f8, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Thu Mar 21 01:20:00 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326154, encodeId=a85f1326154ff, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Thu Mar 21 01:20:00 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373438, encodeId=10ab13e343880, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Thu Mar 21 01:20:00 CST 2019, time=2019-03-21, status=1, ipAttribution=)]
    2019-04-19 hbwxf
  3. [GetPortalCommentsPageByObjectIdResponse(id=1663236, encodeId=018d166323690, content=<a href='/topic/show?id=91a330610e0' target=_blank style='color:#2F92EE;'>#再住院率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30610, encryptionId=91a330610e0, topicName=再住院率)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=515025593328, createdName=12498974m59暂无昵称, createdTime=Mon Oct 21 09:20:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1854336, encodeId=9ac1185433615, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Fri Apr 19 01:20:00 CST 2019, time=2019-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933237, encodeId=b57b193323e94, content=<a href='/topic/show?id=f2563386651' target=_blank style='color:#2F92EE;'>#医保政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33866, encryptionId=f2563386651, topicName=医保政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a8d381, createdName=mnda, createdTime=Sat May 11 03:20:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260431, encodeId=23221260431f8, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Thu Mar 21 01:20:00 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326154, encodeId=a85f1326154ff, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Thu Mar 21 01:20:00 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373438, encodeId=10ab13e343880, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Thu Mar 21 01:20:00 CST 2019, time=2019-03-21, status=1, ipAttribution=)]
    2019-05-11 mnda
  4. [GetPortalCommentsPageByObjectIdResponse(id=1663236, encodeId=018d166323690, content=<a href='/topic/show?id=91a330610e0' target=_blank style='color:#2F92EE;'>#再住院率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30610, encryptionId=91a330610e0, topicName=再住院率)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=515025593328, createdName=12498974m59暂无昵称, createdTime=Mon Oct 21 09:20:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1854336, encodeId=9ac1185433615, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Fri Apr 19 01:20:00 CST 2019, time=2019-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933237, encodeId=b57b193323e94, content=<a href='/topic/show?id=f2563386651' target=_blank style='color:#2F92EE;'>#医保政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33866, encryptionId=f2563386651, topicName=医保政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a8d381, createdName=mnda, createdTime=Sat May 11 03:20:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260431, encodeId=23221260431f8, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Thu Mar 21 01:20:00 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326154, encodeId=a85f1326154ff, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Thu Mar 21 01:20:00 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373438, encodeId=10ab13e343880, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Thu Mar 21 01:20:00 CST 2019, time=2019-03-21, status=1, ipAttribution=)]
    2019-03-21 bioon3
  5. [GetPortalCommentsPageByObjectIdResponse(id=1663236, encodeId=018d166323690, content=<a href='/topic/show?id=91a330610e0' target=_blank style='color:#2F92EE;'>#再住院率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30610, encryptionId=91a330610e0, topicName=再住院率)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=515025593328, createdName=12498974m59暂无昵称, createdTime=Mon Oct 21 09:20:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1854336, encodeId=9ac1185433615, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Fri Apr 19 01:20:00 CST 2019, time=2019-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933237, encodeId=b57b193323e94, content=<a href='/topic/show?id=f2563386651' target=_blank style='color:#2F92EE;'>#医保政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33866, encryptionId=f2563386651, topicName=医保政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a8d381, createdName=mnda, createdTime=Sat May 11 03:20:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260431, encodeId=23221260431f8, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Thu Mar 21 01:20:00 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326154, encodeId=a85f1326154ff, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Thu Mar 21 01:20:00 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373438, encodeId=10ab13e343880, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Thu Mar 21 01:20:00 CST 2019, time=2019-03-21, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1663236, encodeId=018d166323690, content=<a href='/topic/show?id=91a330610e0' target=_blank style='color:#2F92EE;'>#再住院率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30610, encryptionId=91a330610e0, topicName=再住院率)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=515025593328, createdName=12498974m59暂无昵称, createdTime=Mon Oct 21 09:20:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1854336, encodeId=9ac1185433615, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Fri Apr 19 01:20:00 CST 2019, time=2019-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933237, encodeId=b57b193323e94, content=<a href='/topic/show?id=f2563386651' target=_blank style='color:#2F92EE;'>#医保政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33866, encryptionId=f2563386651, topicName=医保政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a8d381, createdName=mnda, createdTime=Sat May 11 03:20:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260431, encodeId=23221260431f8, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Thu Mar 21 01:20:00 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1326154, encodeId=a85f1326154ff, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Thu Mar 21 01:20:00 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1373438, encodeId=10ab13e343880, content=<a href='/topic/show?id=2fd051939ab' target=_blank style='color:#2F92EE;'>#心衰患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51939, encryptionId=2fd051939ab, topicName=心衰患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Thu Mar 21 01:20:00 CST 2019, time=2019-03-21, status=1, ipAttribution=)]

相关资讯

JACC:房颤患者认知功能的降低与亚临床脑损伤相关

房颤患者发生认知功能下降的风险更高,可能是由未知的脑血管损伤引起。本研究的目的旨在评估房颤患者的认知功能和脑血管损伤的相关性。本研究纳入了1737名房颤患者,平均年龄为73 ± 8 岁,女性占28%,90%接受有口服抗凝药物治疗。经过头颅磁共振检查,发现387名(22%)患者有大的非皮质或皮质梗塞(LNCCIs),368名(21%)患者有皮质下小梗死(SNCIs),372名(22%)患者有微出血,

JAHA:血清高密度脂蛋白胆固醇水平与慢性肾脏疾病进展的相关性研究

高密度脂蛋白胆固醇(HDL-C)水平在慢性肾脏疾病(CKD)患者中普遍降低,然而,HDL-C和CKD进展的相关研究甚少。本研究纳入了 KNOW-CKD临床研究中的2168名CKD患者,主要终点事件是肾小球滤过率与基线或终末期肾病相比下降了50%。次要终点事件是终末期肾病的发生。经过平均3.1年时间的随访,335名患者(15.5%)发生了主要终点事件。在多元回归模型分析中,与HDL-C水平在50-5

JAHA:西藏人群代谢危险因素与左室舒张功能的相关性研究

在高海拔和低氧环境下生活的人中,关于代谢危险因素聚类的左心室舒张功能障碍(LVDD)风险的数据尚缺乏。本研究的目的旨在中国西藏人群中探究代谢危险因素与LVDD的相关性。本研究纳入了1963名西藏人群,平均年龄51.51岁,男性占41.11%。其中LVDD的发病率为34.39%,1个危险因素、2个危险因素和3-5个危险因素的LVDD的风险比分别为1.45 (0.96–2.17), 2.68 (1.8

JAHA:术前肌钙蛋白水平可预测主动脉瓣置换术患者的预后

在接受经导管主动脉瓣置换术的患者中,关于肌钙蛋白对患者预后的预测结果有矛盾的结果,本研究的目的旨在评估经导管主动脉瓣置换术前和术后肌钙蛋白对预后的预测价值。本研究纳入了1390名接受经导管主动脉瓣置换术的患者,平均年龄为83.4±6.8 岁,并对所有患者术前和术后的高敏肌钙蛋白水平进行了检测,主要终点事件是1年的死亡率。患者根据术前的肌钙蛋白水平分成了三组:0.001-0.023μg/L;0.02

BMJ:盐摄入与心血管事件及死亡风险

研究发现,极少数人的日常饮食符合WHO推荐的高钾低钠饮食,高钾及中度钠摄入(3-5g/天)人群的与死亡和心血管事件风险最低

Heart:献血与心血管风险

由此可见,该研究结果表明长期、高频率献血对心血管疾病具有保护作用。这种效果仅在女性中观察到,而男性则不然。

Baidu
map
Baidu
map
Baidu
map